Mereo BioPharma Shares Surge Despite Analyst Downgrades

Mereo Biopharma Group PLC shares are trading higher after both Leerink Partners and Jefferies downgraded their price targets to $2 and $0.50, respectively, indicating potential market optimism despite negative analyst sentiment.